Related Experiment Video

Updated: Jun 12, 2026

Rat Mesentery Angiogenesis Assay
18:30

Rat Mesentery Angiogenesis Assay

Published on: June 18, 2011

Anti-angiogenic activity of methanol extract of Phellinus linteus and its fractions

Yeon Sil Lee1, Yoon Hee Kim, Eun Kyung Shin

  • 1Center for Efficacy Assessment and Development of Functional Foods and Drugs, Hallym University, 39 Hallym daehakgil, Chuncheon 200-702, Republic of Korea.

Abstract

Insights

The MeOH extract of PL (PLME) and its fractions effectively inhibited angiogenesis by reducing cell proliferation, migration, and tube formation. These findings suggest PLME

Area of Science:

  • Pharmacology
  • Cell Biology
  • Biochemistry

Background:

  • Angiogenesis is crucial for physiological processes but also implicated in pathological conditions like inflammation and tumor growth.
  • Vascular Endothelial Growth Factor Receptor (VEGFR)-2 signaling plays a key role in regulating endothelial cell functions during angiogenesis.

Purpose of the Study:

  • To investigate the anti-angiogenic potential of the methanol extract of *P. lentiscus* (PLME) and its derived fractions.
  • To evaluate the effects of PLME and its fractions on key cellular processes involved in angiogenesis.

Main Methods:

  • In vitro assessment of PLME and fractions on human umbilical vein endothelial cell (HUVEC) proliferation, migration, and tube formation.
  • Analysis of VEGFR-2 phosphorylation in HUVECs treated with PLME and fractions.
  • In vivo evaluation of anti-angiogenic activity using a Matrigel plug assay.

Main Results:

  • PLME and its methylene chloride, ethyl acetate, and n-butanol fractions significantly inhibited HUVEC proliferation, migration, and tube formation.
  • These active fractions also demonstrated a reduction in VEGFR-2 phosphorylation.
  • In vivo studies confirmed the anti-angiogenic effect of PLME and its fractions in the Matrigel plug model.

Conclusions:

  • PLME possesses significant anti-angiogenic properties, mediated through the inhibition of endothelial cell proliferation, migration, and VEGFR-2 signaling.
  • The findings highlight the therapeutic potential of PLME for managing diseases characterized by excessive angiogenesis, such as inflammation and cancer.

Related Concept Videos